%0 Journal Article %T Non-Chemotherapy Medullary Aplasia in the Pediatric Oncology Unit of the Gabriel Touré Teaching Hospital, Bamako %A Pierre Togo %A Ibrahim Ahamadou %A Tati Simaga %A Abdoul Karim Doumbia %A Fousseyni Traor¨¦ %A Oumar Coulibaly %A Dj¨¦n¨¦ba Konat¨¦ %A Salif Zigm¨¦ %A Adama Demb¨¦l¨¦ %A Mohamed Elmouloud Ciss¨¦ %A Belco Ma£¿ga %A Karamoko Sacko %A Hawa Gouro Diall %A Boubacar Ali Tour¨¦ %A Amadou Tour¨¦ %A Yacouba Aba Coulibaly %A Aminata Doumbia %A Hawa Konar¨¦ %A Kalirou Traor¨¦ %A Souleymane Sagara %A Abdoul Aziz Diakit¨¦ %A Fatoumata Dicko %A Cheick Bougadari Traor¨¦ %A Boubacar Togo %J Open Journal of Pediatrics %P 798-806 %@ 2160-8776 %D 2023 %I Scientific Research Publishing %R 10.4236/ojped.2023.136088 %X Objectives: The main objective was to study the epidemiological, diagnostic and therapeutic aspects of medullary aplasia (MA). Methods: This was a prospective and descriptive retro study conducted from January 1, 2008 to December 31, 2018 in the pediatric oncology unit of the pediatrics department of the Gabriel Tour¨¦ teaching Hospital in Bamako. Results: We collected 29 children¡¯s cases out of 1632 admissions during the study period, representing a frequency of 1.8% and an incidence of 2.6 cases per year. The sex ratio was 2.6. The 11 - 15 age group accounted for 45%, with an average age of 8.93 years. The majority of fathers (55.2%) and mothers (62.1%) had received no education; they were mainly farmers (62.1%) and housewives (86.2%). The average consultation time was 92.21 days. Anemia was the reason for consultation in 69% of cases. Pallor was present on admission in 96.5%; infectious syndrome accounted for 79.3%, anemic syndrome for 51.7% and hemorrhagic syndrome for 27.6%; the three syndromes were associated in 27.6%. Malaria was associated with bone marrow aplasia in 58.6%. Anemia was present in 93.1%, neutropenia in 65.5% and thrombocytopenia in 86.2%. All had received a labile blood product (LBP) transfusion, and 24 (83%) had received antibiotics. Patients were treated with corticosteroids (58.6%), androgens (20.7%) and immunosuppressants (20.7%). The death rate was 34.6%. At last count, 15 (83%) had discontinued treatment, 2 (11%) were undergoing treatment and 1 (6%) was in remission. Conclusion: Effective treatment of MA requires improved technical facilities and better economic conditions for parents. %K Medullar Aplasia %K Children %K Bamako %U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=128894